Empowering Bladder Cancer Care: A Formal Partnership between IBCG and UroToday in the Era of Expanding Therapies
The International Bladder Cancer Group (IBCG) and UroToday, optimizing bladder cancer patient care, AUA-IBCG Bladder Cancer Forum, bladder cancer education, enfortumab vedotin-ejfv in combination with pembrolizumab.